| Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women (NCT05044156) | Usak State Hospital | 2021-10-21 |
| Bioavailability of Flucanazole (NCT04502277) | Sutphin Drugs | 2020-09-01 |
| Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration (NCT04122560) | Radboud University Medical Center | 2019-11-30 |
| PTX3-targeted Antifungal Prophylaxis (NCT03828773) | Bochud Pierre-Yves | 2019-02-11 |
| Validity of Patient-Collected Wet Mounts (NCT02641717) | The University of Texas Health Science Center at San Antonio | 2015-11-01 |
| A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers (NCT02493738) | Boryung Pharmaceutical Co., Ltd | 2015-07-01 |
| Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients (NCT02666716) | Radboud University Medical Center | 2015-05-01 |
| Fluconazole Versus Micafungin in Neonates With Candidiasis (NCT02145832) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-10-01 |
| Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. (NCT03203551) | University of Sao Paulo | 2014-09-01 |
| Candida Host Defense Response After Septic Shock in the Critically Ill (NCT03136081) | University Hospital, Montpellier | 2014-06-01 |
| Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp (NCT02646800) | Astellas Pharma China, Inc. | 2014-03-21 |
| A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia (NCT01982071) | Astellas Pharma China, Inc. | 2013-09-26 |
| Effect of Probiotic Bacteria on Oral Candida in Frail Elderly (NCT02391532) | University of Copenhagen | 2013-09-01 |
| Immunological Interaction Between the Host and Candida Albicans Biofilm (NCT01919931) | Universitaire Ziekenhuizen KU Leuven | 2013-03-01 |
| Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis (NCT00815516) | Astellas Pharma Global Development, Inc. | 2013-02-01 |
| Staging Candidiasis in ICU Patients (NCT01322698) | Centre Hospitalier Universitaire de Nīmes | 2011-10-01 |
| Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine (NCT01447407) | NovaDigm Therapeutics, Inc. | 2011-09-01 |
| Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women (NCT01230814) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom (NCT01202253) | Pfizer | 2011-02-01 |
| Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida (NCT01273922) | NovaDigm Therapeutics, Inc. | 2011-01-01 |
| A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients (NCT01092832) | Pfizer | 2010-10-01 |
| Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections (NCT01102387) | Almirall, S.A. | 2010-02-01 |
| Pre-hospital Risk Factors for Invasive Fungal Infection (NCT01315925) | Catholic University of the Sacred Heart | 2010-01-01 |
| A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China (NCT01253954) | Southeast University, China | 2009-11-01 |
| Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis (NCT00889356) | Zodiac Produtos Farmaceuticos S.A. | 2009-09-01 |
| An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System (NCT00806351) | Pfizer | 2009-08-01 |
| An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida (NCT00805740) | Pfizer | 2009-04-01 |
| Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection (NCT00739934) | Pfizer | 2008-12-01 |
| Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers (NCT00797420) | Daniel Benjamin | 2008-11-01 |
| Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight (NCT00734539) | Daniel Benjamin | 2008-11-01 |
| Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility (NCT00692783) | University of Florida | 2008-05-01 |
| A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection (NCT00784368) | Janssen Pharmaceutical K.K. | 2008-01-01 |
| Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis (NCT00496197) | Pfizer | 2007-07-01 |
| Novel Rinse to Treat in Oral Candidiasis in Cancer Patients (NCT00612963) | Biomedical Development Corporation | 2007-04-01 |
| Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients (NCT00304772) | Kyoto University | 2006-08-01 |
| Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) (NCT00330395) | Merck Sharp & Dohme LLC | 2006-05-01 |
| Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units (NCT00099775) | National Cancer Institute (NCI) | 2004-12-01 |
| Caspofungin Study for Fungal Infections in Adults in Critical Care Settings (NCT00095316) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| Study of Micafungin in Patients With Invasive Candidiasis or Candidemia (NCT00105144) | Astellas Pharma Inc | 2004-09-01 |
| Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) (NCT00083343) | Merck Sharp & Dohme LLC | 2004-05-01 |
| Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) (NCT00082524) | Merck Sharp & Dohme LLC | 2004-04-01 |
| Early Diagnosis of Candidiasis in Premature Infants (NCT00109525) | NICHD Neonatal Research Network | 2004-03-01 |
| Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection (NCT00388167) | PETHEMA Foundation | 2004-03-01 |
| Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments (NCT00313131) | Université de Sherbrooke | 2004-01-01 |
| A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections (NCT00647907) | Pfizer | 2003-04-01 |
| Anidulafungin Versus Fluconazole in the Treatment of Candidemia (NCT00058682) | National Cancer Institute (NCI) | 2003-04-01 |
| The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis (NCT00056368) | Pfizer | 2003-03-01 |
| Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia (NCT00106288) | Astellas Pharma Inc | 2003-01-01 |
| The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) (NCT00041704) | Pfizer | 2002-08-01 |
| Funguria in Hospitalized Patients (NCT00138502) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-17 |
| The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. (NCT00037219) | Pfizer | 2001-08-01 |
| Voriconazole to Prevent Systemic Fungal Infections in Children (NCT00005912) | National Cancer Institute (NCI) | 2000-06-01 |
| Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients (NCT00001937) | National Cancer Institute (NCI) | 1999-11-01 |
| An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections (NCT00001810) | National Cancer Institute (NCI) | 1999-04-01 |
| Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis (NCT00036179) | Astellas Pharma Inc | 1999-02-27 |
| A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. (NCT00163111) | Pfizer | 1998-09-01 |
| Fluconazole Prophylaxis of Thrush in AIDS (NCT00001542) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-07-01 |
| Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy (NCT00002038) | Pfizer | |
| A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women (NCT00000744) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants (NCT00001107) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone (NCT00000788) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) (NCT00000676) | National Institute of Allergy and Infectious Diseases (NIAID) | |